CompletedNot applicableNCT01652573
Calcitonin for Treating X-linked Hypophosphatemia
Studying Hypophosphatemic rickets
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Yale University
- Principal Investigator
- Karl L Insogna, MDProfossor of Medicine, Yale School of Medicine
- Intervention
- nasal salmon calcitonin(drug)
- Enrollment
- 21 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2011 – 2015
Study locations (1)
- Yale School of Medicine, New Haven, Connecticut, United States
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01652573 on ClinicalTrials.gov